Quest Diagnostics Inc (DGX) Share buybacks
- Total buybacks · last 12 months (USD): Value $552.00M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $552.00M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 552.00M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $552.00M | (m) | (m) |
| 2025-12-31 | $450.00M | (m) | (m) |
| 2025-09-30 | $301.00M | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) |
| 2024-12-31 | $151.00M | (m) | (m) |
| 2024-09-30 | $275.00M | (m) | (m) |
| 2023-12-31 | $275.00M | (m) | (m) |
| 2023-09-30 | $461.00M | (m) | (m) |
| 2023-06-30 | $835.00M | (m) | (m) |
| 2023-03-31 | $1.03B | (m) | (m) |
| 2022-12-31 | $1.41B | (m) | (m) |
| 2022-09-30 | $1.24B | (m) | (m) |
| 2022-06-30 | $862.00M | (m) | (m) |
| 2022-03-31 | $2.16B | (m) | (m) |
| 2021-12-31 | $2.20B | (m) | (m) |
| 2021-09-30 | $2.16B | (m) | (m) |
| 2021-06-30 | $2.16B | (m) | (m) |
| 2021-03-31 | $660.00M | (m) | (m) |
| 2020-12-31 | $325.00M | (m) | (m) |
| 2020-09-30 | $275.00M | (m) | (m) |
| 2020-06-30 | $325.00M | (m) | (m) |
| 2020-03-31 | $375.00M | (m) | (m) |
| 2019-12-31 | $353.00M | (m) | (m) |
| 2019-09-30 | $325.00M | (m) | (m) |
| 2019-06-30 | $375.00M | (m) | (m) |
| 2019-03-31 | $325.00M | (m) | (m) |
| 2018-12-31 | $322.00M | (m) | (m) |
| 2018-09-30 | $265.00M | (m) | (m) |
| 2018-06-30 | $215.00M | (m) | (m) |
| 2018-03-31 | $365.00M | (m) | (m) |
| 2017-12-31 | $465.00M | (m) | (m) |
| 2017-09-30 | $500.00M | (m) | (m) |
| 2017-06-30 | $500.00M | (m) | (m) |
| 2017-03-31 | $625.00M | (m) | (m) |
| 2016-12-31 | $590.00M | (m) | (m) |
| 2016-09-30 | $490.00M | (m) | (m) |
| 2016-06-30 | $465.00M | (m) | (m) |
| 2016-03-31 | $229.00M | (m) | (m) |
| 2015-12-31 | $224.00M | (m) | (m) |
| 2015-09-30 | $224.00M | (m) | (m) |
| 2015-06-30 | $224.00M | (m) | (m) |
| 2015-03-31 | $210.00M | (m) | (m) |
| 2014-12-31 | $132.00M | (m) | (m) |
| 2014-09-30 | $125.00M | (m) | (m) |
| 2014-06-30 | $582.00M | (m) | (m) |
| 2014-03-31 | $1.01B | (m) | (m) |
| 2013-12-31 | $1.04B | (m) | (m) |
| 2013-09-30 | $1.04B | (m) | (m) |
| 2013-06-30 | $611.63M | (m) | (m) |
| 2013-03-31 | $211.63M | (m) | (m) |
| 2012-12-31 | $200.00M | (m) | (m) |
| 2012-09-30 | $200.00M | (m) | (m) |
| 2012-06-30 | $199.99M | (m) | (m) |
| 2012-03-31 | $149.99M | (m) | (m) |
| 2011-12-31 | $934.99M | (m) | (m) |
| 2011-09-30 | $885.00M | (m) | (m) |
| 2011-06-30 | $1.16B | (m) | (m) |
| 2011-03-31 | $1.33B | (m) | (m) |
| 2010-12-31 | $750.00M | (m) | (m) |
| 2010-09-30 | $900.00M | (m) | (m) |
| 2010-06-30 | $675.76M | (m) | (m) |
| 2010-03-31 | $500.70M | (m) | (m) |
| 2009-12-31 | $499.99M | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) |
| 2008-12-31 | $254.00M | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) |
| 2007-12-31 | $145.66M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |